Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Antisense Therapeutics Limited (AU: ANP)

 
ANP Technical Analysis
4
As on 6th Mar 2024 ANP STOCK Price closed @ 0.08 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ANPSTOCK Price

Open 0.08 Change Price %
High 0.08 1 Day 0.00 0.00
Low 0.08 1 Week 0.01 14.29
Close 0.08 1 Month 0.02 33.33
Volume 699685 1 Year 0.00 0.00
52 Week High 0.12 | 52 Week Low 0.05
 
AU Australia Most Active Stocks
SYA 0.03 0.00%
DTR 0.20 25.00%
TLS 4.85 -2.61%
IXR 0.02 0.00%
PLS 2.16 0.93%
MRD 0.00 %
TMG 0.10 0.00%
VR1 0.04 0.00%
LTR 0.80 -9.09%
S32 2.90 -5.23%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
X2M 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
ACR 0.02 100.00%
 
AU Australia Top Losers Stocks
RCP 0.02 -33.33%
RCP 0.02 -33.33%
WLD 0.03 -25.00%
HGO 0.03 -25.00%
ZNO 0.03 -25.00%
GRV 0.04 -20.00%
GRV 0.04 -20.00%
GRV 0.04 -20.00%
GRV 0.04 -20.00%
GRV 0.04 -20.00%
 
 
ANP
Daily Charts		 ANP
Intraday Charts		 Whats New @
Bazaartrend		 ANP
Free Analysis
 
ANP Important Levels Intraday
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
 
ANP Forecast August 2025
Share
4th UP Forecast0.16
3rd UP Forecast0.13
2nd UP Forecast0.12
1st UP Forecast0.1
1st DOWN Forecast0.06
2nd DOWN Forecast0.04
3rd DOWN Forecast0.03
4th DOWN Forecast0
 
ANP Weekly Forecast
4th UP Forecast0.10
3rd UP Forecast0.09
2nd UP Forecast0.09
1st UP Forecast0.09
1st DOWN Forecast0.07
2nd DOWN Forecast0.07
3rd DOWN Forecast0.07
4th DOWN Forecast0.06
 
ANP Forecast2025
4th UP Forecast0.21
3rd UP Forecast0.17
2nd UP Forecast0.14
1st UP Forecast0.12
1st DOWN Forecast0.04
2nd DOWN Forecast0.02
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.05
 
 
ANP Other Details
Segment EQ
Market Capital 169470416.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
ANP Address
ANP
 
ANP Latest News
 
Your Comments and Response on Antisense Therapeutics Limited
 
ANP Business Profile
Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Address: 14 Wallace Avenue, Toorak, VIC, Australia, 3142
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service